Embla Medical Announces New Executive Vice President of R&D
Reykjavik, Iceland/Copenhagen, Denmark, February 24, 2025. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today announced that André Rocha has been appointed Executive Vice President of Research and Development (R&D) at Embla Medical.
Mr. Rocha has served as Partner at global management consulting firm, McKinsey & Company, for the last 13 years, and brings 25 years of experience and a proven track record across all levels of organizations. His career also includes several R&D roles at Nokia (formerly Nokia Siemens Networks), and he has led teams across a wide range of geographies and cultures, including the Nordics, Iberia, Germany, the U.S., India and Japan.
Mr. Rocha holds an MBA from the European School of Management and Technology in Berlin, a Master of Science degree in Economics, and a Bachelor of Science degree in Electrical and Computer Engineering, both from the University of Porto.
“We are very excited to welcome André Rocha to Embla Medical. His vast experience in R&D, engineering and product development make him well-suited to lead our innovation efforts and contribute to developing advanced solutions for people with mobility challenges,” said Sveinn Sölvason, Embla Medical President and CEO.
Further information
Klaus Sindahl, Head of Investor Relations, [email protected], +45 5363 0134
Edda H. Geirsdottir, VP of Corporate Communication, [email protected], + 354 664 1055
Embla Medical press releases by e-mail
If you wish to receive Embla Medical press releases by e-mail, please register at